Catalyst Wire Dossier Catalyst Wire Dossier

Desvenlafaxine

Desvenlafaxine · Actavis Pharma, Inc.
Drug timelines are a Plus or Pro feature.

37 regulatory and trial events tracked for Desvenlafaxine, covering 2007-12-05 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Desvenlafaxine for Preventive Treatment of Frequent Migraines [NA]

See pricing